Feingold Jay has filed 6 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 209803 shares of Pyxis Oncology, Inc. ($PYXS) on March 24, 2023.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 24, 2023 | Pyxis Oncology, Inc. | $PYXS | Feingold Jay | Chief Medical Officer | A | Common Stock | 209803 | $0.00 | 730,345.0000 | 0 | 40.30% | 0.00% |
| March 24, 2023 | Pyxis Oncology, Inc. | $PYXS | Feingold Jay | Chief Medical Officer | D | Stock Option (Right to buy) | 157257 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 24, 2023 | Pyxis Oncology, Inc. | $PYXS | Feingold Jay | Chief Medical Officer | D | Stock Option (Right to buy) | 17517 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 24, 2023 | Pyxis Oncology, Inc. | $PYXS | Feingold Jay | Chief Medical Officer | A | Stock Option (Right to buy) | 157257 | $0.00 | 157,257.0000 | 0 | 9999.99% | 0.00% |
| March 24, 2023 | Pyxis Oncology, Inc. | $PYXS | Feingold Jay | Chief Medical Officer | A | Stock Option (Right to buy) | 17517 | $0.00 | 17,517.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2023 | Pyxis Oncology, Inc. | $PYXS | Feingold Jay | Chief Medical Officer | A | Common Stock | 53931 | $0.00 | 520,542.0000 | 0 | 11.56% | 0.00% |